News | Computed Tomography (CT) | December 14, 2017

Mirada Medical and Optellum Debut AI-Based Lung Cancer Diagnosis Solution at RSNA 2017

Scientific presentation outlines benefits of deep learning algorithm that assigns objective risk score of nodule malignancy

Mirada Medical and Optellum Debut AI-Based Lung Cancer Diagnosis Solution at RSNA 2017

December 14, 2017 — Optellum, a high-tech startup in lung cancer and machine learning, and Mirada Medical recently announced a partnership to accelerate the deployment of deep learning technology to market. This collaboration combines the deep technology and clinical expertise of Optellum with the software platforms and rapid development know-how of Mirada. They have partnered to address what they call a huge and growing problem in lung cancer diagnosis: the management of patients with indeterminate pulmonary nodules.

A scientific presentation arising from the partnership working in collaboration with investigators from Oxford University Hospitals, entitled “Assessment of CT Texture Analysis as a Tool for Lung Nodule Follow-Up” (SSC03-02), was presented at the 2017 Radiological Society of North America (RSNA) Annual Meeting, Nov. 26-Dec. 1 in Chicago.

Early detection of lung cancer by a chest computed tomography (CT) scan can dramatically improve survival rates. Millions of chest CT scans are performed for a variety of reasons, ranging from screening for lung cancer to scanning for suspected cardiac disease or even following trauma. Such scans frequently identify pulmonary nodules, small opacities in the lung. Up to 30 percent of all patients scanned have such small nodules, but the vast majority are harmless. Unfortunately, radiologists frequently struggle to determine if a nodule is cancerous, leading to an indeterminate diagnosis which requires up to two-year follow-up imaging to monitor growth. Moreover, additional biopsies and surgeries are often performed to investigate nodules that ultimately turn out to be benign. Millions of such unnecessary follow-up scans and procedures increase patient anxiety, carry a risk of complications and present a huge and growing burden on healthcare system resources.

The collaboration has developed what it calls the world’s first imaging artificial intelligence (AI)-based decision support software to improve patient management and reduce unnecessary follow-up procedures. The software provides expert-level clinical decision support that can improve a doctor’s ability to correctly diagnose lung nodules. The software, utilizing state-of-the-art deep learning, provides an objective risk score of nodule malignancy learned from a database of tens of thousands of CTs with known ground-truth diagnoses. The output enables clinicians to confidently stratify lung nodule patients earlier, potentially on the basis of only one or two scans.

The team showcased their work at the Mirada Medical booth at RSNA 2017.

For more information: www.mirada-medical.com

Related Content

FDA Clears Bay Labs' EchoMD AutoEF Software for AI Echo Analysis
Technology | Cardiovascular Ultrasound | June 19, 2018
Cardiovascular imaging artificial intelligence (AI) company Bay Labs announced its EchoMD AutoEF software received 510(...
Report Finds Identifying Patients for Lung Cancer Screening Not So Simple
News | Lung Cancer | June 18, 2018
New findings in the current issue of The American Journal of Managed Care suggest that getting the right patients to...
Weight-Bearing CT International Study Group Hosts  Scientific Session at AOFAS Conference
News | Computed Tomography (CT) | June 15, 2018
June 15, 2018 —The Weight-Bearing CT International Study Group will host a scientific session on the benefits of weig
Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co.
News | Remote Viewing Systems | June 14, 2018
International Medical Solutions (IMS) recently announced that the American College of Radiology (ACR) added IMS'...
Riverain Technologies Issued U.S. Patent for Vessel Suppression Technology
News | Computed Tomography (CT) | June 14, 2018
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a...
360 Photos | 360 View Photos | June 14, 2018
This is a 360 degree image from the Canon Aquilion 64-slice...
Wake Radiology Launches First Installation of EnvoyAI Platform
News | Artificial Intelligence | June 13, 2018
Artificial intelligence (AI) platform provider EnvoyAI recently completed their first successful customer installation...
American Society of Neuroradiology Honors Peter Chang with Cornelius G. Dyke Memorial Award
News | Neuro Imaging | June 13, 2018
Peter Chang, M.D., current neuroradiology fellow at UCSF and recently recruited co-director of the UCI Center for...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
Overlay Init